Hangzhou-based biotech start-up MindRank has progressed to Phase 3 clinical trials for its weight-loss drug, making it China's first artificial intelligence-assisted Category 1 new drug to reach this ...
Real estate businesses concluded 2025 with breakthroughs in business, including projects relaunching on the market. Entering ...
A new microchip-sized device could dramatically accelerate the future of quantum computing. It controls laser frequencies ...
Mutuum Finance (MUTM), a new crypto project focused on decentralized lending and borrowing, has entered Phase 7 of its token ...
ArriVent BioPharma's furmonertinib demonstrates robust efficacy, CNS penetration, and tolerability in early trials. Read why ...
Snowbirds used to get a sweet deal on Bend’s sewer service. They would not only avoid Central Oregon’s cold winter by moving ...
Avoid cheap hair transplant pitfalls: learn why low cost risks graft loss and poor aftercare, and how to vet clinics, ...
The crypto exchange is closing down operations in phases from Dec. 27, 2025, to March 31, 2026. Crypto exchange Bit.com has ...
After nearly 1,000 days of fighting, ceasefire politics, sanctions and regional calculations are managing Sudan’s collapse ...
Vanda Pharmaceuticals received FDA approval for Nereus for motion sickness, and its shares offer upside potential into 2026 ...
SB Nation on MSN
Surprise! The Giants have increased their budget
For their part, the Giants have tempered expectations with discussions of fiscal responsibility and servicing shareholders ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback